Mark W. Lingen - Publications

Affiliations: 
Cancer Biology University of Chicago, Chicago, IL 
Area:
Molecular Biology, Oncology, Biochemistry

121 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Khammanivong A, Sorenson BS, Ross KF, Dickerson EB, Hasina R, Lingen MW, Herzberg MC. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC. Oncotarget. PMID 26883112 DOI: 10.18632/oncotarget.7373  1
2015 Rowley AH, Wylie KM, Kim KY, Pink AJ, Yang A, Reindel R, Baker SC, Shulman ST, Orenstein JM, Lingen MW, Weinstock GM, Wylie TN. The transcriptional profile of coronary arteritis in Kawasaki disease. Bmc Genomics. 16: 1076. PMID 26679344 DOI: 10.1186/s12864-015-2323-5  1
2015 William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, et al. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. Jama Oncology. 1-8. PMID 26540028 DOI: 10.1001/jamaoncol.2015.4364  1
2015 Gillard M, Tom WR, Antic T, Paner GP, Lingen MW, VanderWeele DJ. Next-gen tissue: preservation of molecular and morphological fidelity in prostate tissue. American Journal of Translational Research. 7: 1227-35. PMID 26328007  1
2015 Xiao H, Langerman A, Zhang Y, Khalid O, Hu S, Cao CX, Lingen MW, Wong DT. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery. Oral Oncology. PMID 26321370 DOI: 10.1016/j.oraloncology.2015.08.008  1
2015 Zhong R, Bao R, Faber PW, Bindokas VP, Bechill J, Lingen MW, Spiotto MT. Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis. Cancer Research. 75: 3958-69. PMID 26294213 DOI: 10.1158/0008-5472.CAN-15-0199  1
2015 Lingen MW. Welcome R. Bryan Bell, DDS, MD, FACS, FACD. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 119: 485. PMID 25804874 DOI: 10.1016/j.oooo.2015.02.001  1
2015 Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, et al. AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2601-12. PMID 25767293 DOI: 10.1158/1078-0432.CCR-14-2648  1
2015 Schechter RB, Nagilla M, Joseph L, Reddy P, Khattri A, Watson S, Locati LD, Licitra L, Greco A, Pelosi G, Carcangiu ML, Lingen MW, Seiwert TY, Cohen EE. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. Cancer Letters. 359: 269-74. PMID 25641339 DOI: 10.1016/j.canlet.2015.01.024  1
2015 Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Brägelmann J, DeBoer R, El-Dinali M, Aktolga S, Lei Z, Tan P, ... ... Lingen MW, et al. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 870-81. PMID 25492084 DOI: 10.1158/1078-0432.CCR-14-2481  1
2015 Lingen MW. Triple O has gone virtual! Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 119: 1-2. PMID 25482546 DOI: 10.1016/j.oooo.2014.10.001  1
2015 Khattri A, Zuo Z, Brägelmann J, Keck MK, El Dinali M, Brown CD, Stricker T, Munagala A, Cohen EE, Lingen MW, White KP, Vokes EE, Seiwert TY. Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma. Oral Oncology. 51: 53-8. PMID 25255959 DOI: 10.1016/j.oraloncology.2014.08.014  1
2014 Ferguson BD, Tretiakova MS, Lingen MW, Gill PS, Salgia R. Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition. Growth Factors (Chur, Switzerland). 32: 202-6. PMID 25391996 DOI: 10.3109/08977194.2014.980904  1
2014 Tower JI, Lingen MW, Seiwert TY, Langerman A. Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinoma. American Journal of Translational Research. 6: 548-57. PMID 25360219  1
2014 Seiwert TY, Wang X, Heitmann J, Villegas-Bergazzi V, Sprott K, Finn S, O'Regan E, Farrow AD, Weichselbaum RR, Lingen MW, Cohen EE, Stenson K, Weaver DT, Vokes EE. DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. Plos One. 9: e102112. PMID 25019640 DOI: 10.1371/journal.pone.0102112  1
2014 Reindel R, Bischof J, Kim KY, Orenstein JM, Soares MB, Baker SC, Shulman ST, Perlman EJ, Lingen MW, Pink AJ, Trevenen C, Rowley AH. CD84 is markedly up-regulated in Kawasaki disease arteriopathy. Clinical and Experimental Immunology. 177: 203-11. PMID 24635044 DOI: 10.1111/cei.12327  1
2014 Kuo WL, Sharifi MN, Lingen MW, Ahmed O, Liu J, Nagilla M, Macleod KF, Cohen EE. p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. Plos One. 9: e90171. PMID 24599075 DOI: 10.1371/journal.pone.0090171  1
2014 Paral KM, Taxy JB, Lingen MW. CD34 and α smooth muscle actin distinguish verrucous hyperplasia from verrucous carcinoma. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 117: 477-82. PMID 24560559 DOI: 10.1016/j.oooo.2013.12.401  1
2014 Reindel R, Kim KY, Baker SC, Shulman ST, Perlman EJ, Lingen MW, Trevenen C, Rowley AH. Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker. The Pediatric Infectious Disease Journal. 33: 659-61. PMID 24476956 DOI: 10.1097/INF.0000000000000233  1
2014 Lauxen IS, Oliveira MG, Rados PV, Lingen MW, Nör JE, Sant'Ana Filho M. Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression Oral Diseases. 20. PMID 23738964 DOI: 10.1111/odi.12136  1
2013 Zhao L, Antic T, Witten D, Paner GP, Taxy JB, Husain A, Gwin K, Mirza MK, Lingen MW, Tretiakova MS. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. The American Journal of Surgical Pathology. 37: 1876-81. PMID 24121175 DOI: 10.1097/PAS.0b013e31829e2525  1
2013 Squarize CH, Castilho RM, Abrahao AC, Molinolo A, Lingen MW, Gutkind JS. PTEN deficiency contributes to the development and progression of head and neck cancer. Neoplasia (New York, N.Y.). 15: 461-71. PMID 23633918 DOI: 10.1593/neo.121024  1
2013 Liang H, Deng L, Chmura S, Burnette B, Liadis N, Darga T, Beckett MA, Lingen MW, Witt M, Weichselbaum RR, Fu YX. Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. Journal of Immunology (Baltimore, Md. : 1950). 190: 5874-81. PMID 23630355 DOI: 10.4049/jimmunol.1202612  1
2013 Brägelmann J, Dagogo-Jack I, El Dinali M, Stricker T, Brown CD, Zuo Z, Khattri A, Keck M, McNerney ME, Longnecker R, Bieging K, Kocherginsky M, Alexander K, Salgia R, Lingen MW, et al. Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncology. 49: 525-33. PMID 23490885 DOI: 10.1016/j.oraloncology.2013.02.003  1
2013 Reindel R, Baker SC, Kim KY, Rowley CA, Shulman ST, Orenstein JM, Perlman EJ, Lingen MW, Rowley AH. Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy. Pediatric Research. 73: 332-6. PMID 23344661 DOI: 10.1038/pr.2012.185  1
2013 Brennan PA, Wiltfang J, Samman N, Lingen MW, Hupp JR. Journal alliance to address issues of dual submission and plagiarism. The British Journal of Oral & Maxillofacial Surgery. 51: 1. PMID 23313041 DOI: 10.1016/j.bjoms.2012.09.001  1
2013 Samman N, Brennan PA, Wiltfang J, Lingen MW, Hupp JR. Journal alliance to address issues of dual submission and plagiarism. International Journal of Oral and Maxillofacial Surgery. 42: 1. PMID 23290661 DOI: 10.1016/j.ijom.2012.09.007  1
2013 Wiltfang J, Brennan PA, Samman N, Lingen MW, Hupp JR. Journal alliance to address issues of dual submission and plagiarism. Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association For Cranio-Maxillo-Facial Surgery. 41: 1. PMID 23290255 DOI: 10.1016/j.jcms.2012.09.004  1
2013 Hupp JR, Brennan PA, Lingen MW, Samman N, Wiltfang J. Journal alliance to address issues of dual submission and plagiarism. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 71: 3. PMID 23245771 DOI: 10.1016/j.joms.2012.09.004  1
2013 Lingen MW, Brennan PA, Wiltfang J, Samman N, Hupp JR. Journal alliance to address issues of dual submission and plagiarism. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 115: 1. PMID 23217533 DOI: 10.1016/j.oooo.2012.09.010  1
2013 Seiwert TY, Darga T, Haraf D, Blair EA, Stenson K, Cohen EE, Salama JK, Villaflor V, Witt ME, Lingen MW, Weichselbaum RR, Vokes EE. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeâ„¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 769-76. PMID 23104721 DOI: 10.1093/annonc/mds523  1
2013 Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, ... ... Lingen MW, et al. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Research. 73: 184-94. PMID 23100466 DOI: 10.1158/0008-5472.CAN-12-0915  1
2013 Doçi CL, Zhou G, Lingen MW. The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression. Oncogene. 32: 4377-86. PMID 23085760 DOI: 10.1038/onc.2012.464  1
2013 Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncology. 49: 1-8. PMID 22841678 DOI: 10.1016/j.oraloncology.2012.07.002  1
2012 Mankame TP, Lingen MW. The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7. Neoplasia (New York, N.Y.). 14: 1213-22. PMID 23308053 DOI: 10.1593/neo.121422  1
2012 Lingen MW, Szabo E. Validation of LOH profiles for assessing oral cancer risk. Cancer Prevention Research (Philadelphia, Pa.). 5: 1075-7. PMID 22911110 DOI: 10.1158/1940-6207.CAPR-12-0294  1
2012 Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW, Patton LL, Perkins D, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Texas Dental Journal. 129: 491-507. PMID 22779205  1
2012 Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. The American Journal of Surgical Pathology. 36: 945-54. PMID 22743284 DOI: 10.1097/PAS.0b013e318253a2d1  1
2012 Lingen MW. Looking back as we move forward. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 113: 1. PMID 22669063 DOI: 10.1016/j.tripleo.2011.09.002  1
2012 Wu X, Chen P, Sonis ST, Lingen MW, Berger A, Toback FG. A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis. International Journal of Radiation Oncology, Biology, Physics. 83: e409-15. PMID 22420966 DOI: 10.1016/j.ijrobp.2012.01.006  1
2012 de Souza JA, Davis DW, Zhang Y, Khattri A, Seiwert TY, Aktolga S, Wong SJ, Kozloff MF, Nattam S, Lingen MW, Kunnavakkam R, Stenson KM, Blair EA, Bozeman J, Dancey JE, et al. A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2336-43. PMID 22371453 DOI: 10.1158/1078-0432.CCR-11-2825  1
2012 Bainer RO, Veneris JT, Yamada SD, Montag A, Lingen MW, Gilad Y, Rinker-Schaeffer CW. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clinical & Experimental Metastasis. 29: 397-408. PMID 22350525 DOI: 10.1007/s10585-011-9448-y  1
2012 Doçi CL, Mankame TP, Langerman A, Ostler KR, Kanteti R, Best T, Onel K, Godley LA, Salgia R, Lingen MW. Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 31: 15-24. PMID 22123719 DOI: 10.1097/PGP.0b013e318220ba16  1
2011 Lingen MW. Brush-based cytology screening in the tonsils and cervix: there is a difference! Cancer Prevention Research (Philadelphia, Pa.). 4: 1350-2. PMID 21893496 DOI: 10.1158/1940-6207.CAPR-11-0373  1
2011 Glubb DM, Cerri E, Giese A, Zhang W, Mirza O, Thompson EE, Chen P, Das S, Jassem J, Rzyman W, Lingen MW, Salgia R, Hirsch FR, Dziadziuszko R, Ballmer-Hofer K, et al. Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5257-67. PMID 21712447 DOI: 10.1158/1078-0432.CCR-11-0379  1
2011 Lingen MW. Assuring dental student head and neck cancer screening competency. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 111: 267-8. PMID 21310351 DOI: 10.1016/j.tripleo.2010.11.024  1
2011 Leeman-Neill RJ, Seethala RR, Singh SV, Freilino ML, Bednash JS, Thomas SM, Panahandeh MC, Gooding WE, Joyce SC, Lingen MW, Neill DB, Grandis JR. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prevention Research (Philadelphia, Pa.). 4: 230-7. PMID 21163936 DOI: 10.1158/1940-6207.CAPR-10-0249  1
2010 Zhou G, Hasina R, Wroblewski K, Mankame TP, Doçi CL, Lingen MW. Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 3: 1493-502. PMID 20978113 DOI: 10.1158/1940-6207.CAPR-10-0135  1
2010 Zhou G, Doçi CL, Lingen MW. Identification and functional analysis of NOL7 nuclear and nucleolar localization signals. Bmc Cell Biology. 11: 74. PMID 20875127 DOI: 10.1186/1471-2121-11-74  1
2010 Lingen MW. Screening for oral premalignancy and cancer: what platform and which biomarkers? Cancer Prevention Research (Philadelphia, Pa.). 3: 1056-9. PMID 20798207 DOI: 10.1158/1940-6207.CAPR-10-0173  1
2010 Lingen MW. Can saliva-based HPV tests establish cancer risk and guide patient management? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 110: 273-4. PMID 20727494 DOI: 10.1016/j.tripleo.2010.06.002  1
2010 Cohen EE, Haraf DJ, Kunnavakkam R, Stenson KM, Blair EA, Brockstein B, Lester EP, Salama JK, Dekker A, Williams R, Witt ME, Grushko TA, Dignam JJ, Lingen MW, Olopade OI, et al. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3336-43. PMID 20498391 DOI: 10.1200/JCO.2009.27.0397  1
2010 Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW, Patton LL, Perkins D, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Journal of the American Dental Association (1939). 141: 509-20. PMID 20436098  1
2010 Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, Li J, Hasina R, Cheng C, Lingen MW, Gerstein MB, Weichselbaum RR, Xing HR, Lussier YA. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. Plos Computational Biology. 6: e1000730. PMID 20369013 DOI: 10.1371/journal.pcbi.1000730  1
2010 Lingen MW. Pragmatics versus contrarians: how does one resolve their differences with respect to oral cancer screening? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 109: 325-6. PMID 20219595 DOI: 10.1016/j.tripleo.2009.12.022  1
2010 Rothenberg SM, Mohapatra G, Rivera MN, Winokur D, Greninger P, Nitta M, Sadow PM, Sooriyakumar G, Brannigan BW, Ulman MJ, Perera RM, Wang R, Tam A, Ma XJ, Erlander M, ... ... Lingen MW, et al. A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Research. 70: 2158-64. PMID 20215515 DOI: 10.1158/0008-5472.CAN-09-3458  1
2010 Mankame TP, Zhou G, Lingen MW. Identification and characterization of the human NOL7 gene promoter. Gene. 456: 36-44. PMID 20206243 DOI: 10.1016/j.gene.2010.02.008  1
2010 Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nör JE. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death and Differentiation. 17: 499-512. PMID 19834490 DOI: 10.1038/cdd.2009.152  1
2009 Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, Goel K, Gomes S, Liu Y, Abe MK, Nor JE, Lingen MW, Rosner MR. A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. Blood. 114: 4592-600. PMID 19710505 DOI: 10.1182/blood-2009-04-217042  1
2009 Lingen MW. Point of care salivary diagnostics for systemic disease screening: if someone builds it, will dentistry come? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 108: 309-10. PMID 19596207 DOI: 10.1016/j.tripleo.2009.06.003  1
2009 Hasina R, Martin LE, Kasza K, Jones CL, Jalil A, Lingen MW. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 2: 385-93. PMID 19336725 DOI: 10.1158/1940-6207.CAPR-08-0211  1
2009 Lingen MW. Direct-to-consumer advertising for oral cancer screening devices. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 107: 299-300. PMID 19157922 DOI: 10.1016/j.tripleo.2008.12.013  1
2009 Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, Kocherginsky M, Parker JS, Chung CH, Rosner MR. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Research. 69: 65-74. PMID 19117988 DOI: 10.1158/0008-5472.CAN-08-0377  1
2009 Chow CK, Zhu H, Lacy J, Lingen MW, Kuo WP, Chan K. A cooperative feature gene extraction algorithm that combines classification and clustering Proceedings - 2009 Ieee International Conference On Bioinformatics and Biomedicine Workshops, Bibmw 2009. 197-202. DOI: 10.1109/BIBMW.2009.5332126  1
2008 Lingen MW. The changing face of head and neck cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 106: 315-6. PMID 18707653 DOI: 10.1016/j.tripleo.2008.06.001  1
2008 Lingen MW. Cause-related marketing: the uneasy alliance between altruism and corporate greed. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 105: 407-9. PMID 18329575 DOI: 10.1016/j.tripleo.2008.01.020  1
2008 Hasina R, Whipple ME, Martin LE, Kuo WP, Ohno-Machado L, Lingen MW. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 342-53. PMID 18283272 DOI: 10.1038/labinvest.2008.6  1
2008 Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen MW. Tissue microarray - a high-throughput molecular analysis in head and neck cancer. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 37: 166-76. PMID 18251941 DOI: 10.1111/j.1600-0714.2007.00606.x  1
2008 Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, Loganathan S, Kanteti R, Reichman T, Nallasura V, Schwartz S, Faoro L, Wang YC, Girard L, Tretiakova MS, ... ... Lingen MW, et al. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Research. 68: 132-42. PMID 18172305 DOI: 10.1158/0008-5472.CAN-07-1998  1
2008 Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncology. 44: 10-22. PMID 17825602 DOI: 10.1016/j.oraloncology.2007.06.011  1
2008 Lingen MW. In reply Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 106: 827-828. DOI: 10.1016/j.tripleo.2008.04.028  1
2008 Lingen MW, Kalmar JR, Karrison T, Speight PM. Response to the comments by Eisen on 'Critical evaluation of diagnostic aids for the detection of oral cancer' Oral Oncology. 44: 997-998. DOI: 10.1016/j.oraloncology.2008.07.001  1
2008 Lingen MW, Kalmar JR, Karrison T, Speight PM. Reply to the comments on "Critical evaluation of diagnostic aids for the detection of oral cancer", Oral Oncology. 44: 520-522. DOI: 10.1016/j.oraloncology.2008.01.007  1
2007 Lingen MW. Improving translational research for oral cancer screening aids: putting my "money" where my mouth is. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 104: 301-2. PMID 17709071 DOI: 10.1016/j.tripleo.2007.07.024  1
2007 Hong J, Doebele RC, Lingen MW, Quilliam LA, Tang WJ, Rosner MR. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. The Journal of Biological Chemistry. 282: 19781-7. PMID 17491018 DOI: 10.1074/jbc.M700128200  1
2007 Lingen MW. Oral cancer screening aids: where is the science? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 103: 153-4. PMID 17234527 DOI: 10.1016/j.tripleo.2006.11.027  1
2006 Nickoloff BJ, Bonish BK, Marble DJ, Schriedel KA, DiPietro LA, Gordon KB, Lingen MW. Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation. The Journal of Investigative Dermatology. Symposium Proceedings / the Society For Investigative Dermatology, Inc. [and] European Society For Dermatological Research. 11: 16-29. PMID 17069007 DOI: 10.1038/sj.jidsymp.5650010  1
2006 Lingen MW. Tales of academic dishonesty and what do we do about it? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 102: 429-30. PMID 16997105 DOI: 10.1016/j.tripleo.2006.08.010  1
2006 Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvascular Research. 72: 3-11. PMID 16820176 DOI: 10.1016/j.mvr.2006.04.004  1
2006 Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Research. 66: 6296-303. PMID 16778206 DOI: 10.1158/0008-5472.CAN-05-3139  1
2006 Connell PP, Jayathilaka K, Haraf DJ, Weichselbaum RR, Vokes EE, Lingen MW. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. International Journal of Oncology. 28: 1113-9. PMID 16596227  1
2006 Antico G, Lingen MW, Sassano A, Melby J, Welch RW, Fiore S, Pilon AL, Miele L. Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin. Journal of Cellular Physiology. 207: 553-61. PMID 16453303 DOI: 10.1002/jcp.20604  1
2006 Hasina R, Pontier AL, Fekete MJ, Martin LE, Qi XM, Brigaudeau C, Pramanik R, Cline EI, Coignet LJ, Lingen MW. NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype Oncogene. 25: 588-598. PMID 16205646 DOI: 10.1038/sj.onc.1209070  1
2005 Cohen EE, Lingen MW, Martin LE, Harris PL, Brannigan BW, Haserlat SM, Okimoto RA, Sgroi DC, Dahiya S, Muir B, Clark JR, Rocco JW, Vokes EE, Haber DA, Bell DW. Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8105-8. PMID 16299242 DOI: 10.1158/1078-0432.CCR-05-0926  1
2004 Hasina R, Lingen MW. Head and neck cancer: the pursuit of molecular diagnostic markers. Seminars in Oncology. 31: 718-25. PMID 15599849 DOI: 10.1053/j.seminoncol.2004.09.012  1
2004 Vokes EE, Lingen MW. Update in head and neck oncology. Seminars in Oncology. 31: 717. PMID 15599848 DOI: 10.1053/j.seminoncol.2004.09.004  1
2004 Petro BJ, Tan RC, Tyner AL, Lingen MW, Watanabe K. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium Oral Oncology. 40: 1040-1047. PMID 15509496 DOI: 10.1016/j.oraloncology.2004.05.010  1
2004 Nickoloff BJ, Lingen MW, Chang BD, Shen M, Swift M, Curry J, Bacon P, Bodner B, Roninson IB. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Research. 64: 2956-61. PMID 15126325 DOI: 10.1158/0008-5472.CAN-03-2388  1
2004 Cohen EE, Lingen MW, Vokes EE. The expanding role of systemic therapy in head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1743-52. PMID 15117998 DOI: 10.1200/JCO.2004.06.147  1
2003 Dettin M, Bicciato S, Scarinci C, Cline E, Lingen MW, Di Bello C. Synthetic peptides derived from the angiostatin K4 domain inhibit endothelial cell migration. Chembiochem : a European Journal of Chemical Biology. 4: 1238-42. PMID 14613119 DOI: 10.1002/cbic.200300711  1
2003 Kuo WP, Hasina R, Ohno-Machado L, Lingen MW. Classification and identification of genes associated with oral cancer based on gene expression profiles. A preliminary study. The New York State Dental Journal. 69: 23-6. PMID 12703240  1
2003 Hasina R, Hulett K, Bicciato S, Di Bello C, Petruzzelli GJ, Lingen MW. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Cancer Research. 63: 555-9. PMID 12566295  1
2002 Cline EI, Bicciato S, DiBello C, Lingen MW. Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling. Cancer Research. 62: 7143-8. PMID 12499246  1
2002 Kuo WP, Jenssen TK, Park PJ, Lingen MW, Hasina R, Ohno-Machado L. Gene expression levels in different stages of progression in oral squamous cell carcinoma. Proceedings / Amia ... Annual Symposium. Amia Symposium. 415-9. PMID 12474876  1
2002 Todd R, Lingen MW, Kuo WP. Gene expression profiling using laser capture microdissection. Expert Review of Molecular Diagnostics. 2: 497-507. PMID 12271821 DOI: 10.1586/14737159.2.5.497  1
2002 Liss C, Fekete MJ, Hasina R, Lingen MW. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma. International Journal of Cancer. 100: 283-9. PMID 12115542 DOI: 10.1002/ijc.10507  1
2002 Wei PC, Laurell L, Lingen MW, Geivelis M. Acellular dermal matrix allografts to achieve increased attached gingiva. Part 2. A histological comparative study. Journal of Periodontology. 73: 257-65. PMID 11922254 DOI: 10.1902/jop.2002.73.3.257  1
2002 Curry JL, Petruzzelli GJ, McClatchey KD, Lingen MW. Synchronous benign and malignant salivary gland tumors in ipsilateral glands: a report of two cases and a review of literature. Head & Neck. 24: 301-6. PMID 11891964 DOI: 10.1002/hed.10048  1
2002 Matthies AM, Low QE, Lingen MW, DiPietro LA. Neuropilin-1 participates in wound angiogenesis. The American Journal of Pathology. 160: 289-96. PMID 11786422 DOI: 10.1016/S0002-9440(10)64372-6  1
2001 Hasina R, Lingen MW. Angiogenesis in oral cancer Journal of Dental Education. 65: 1282-1290. PMID 11765876  1
2001 Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages International Journal of Cancer. 93: 781-785. PMID 11519037 DOI: 10.1002/ijc.1407  1
2001 Kini AR, Peterson LA, Tallman MS, Lingen MW. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood. 97: 3919-24. PMID 11389035 DOI: 10.1182/blood.V97.12.3919  1
2001 Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing Archives of Pathology and Laboratory Medicine. 125: 67-71. PMID 11151055  1
2000 Sommercorn LM, Di Fiore PM, Dixit SN, Koerber A, Lingen MW, Veis A. Effect of alendronate on immature human dental root explants Journal of Endodontics. 26: 133-137. PMID 11199704  1
2000 Lingen MW, Emami B, Clark JI. New therapeutic strategies for the treatment and prevention of head and neck cancer Expert Opinion On Investigational Drugs. 9: 2855-2872. PMID 11093357  1
2000 Wei PC, Laurell L, Geivelis M, Lingen MW, Maddalozzo D. Acellular dermal matrix allografts to achieve increased attached gingiva. Part 1. A clinical study Journal of Periodontology. 71: 1297-1305. PMID 10972645  1
2000 Lingen MW, Chang KW, McMurray SJ, Solt DB, Kies MS, Mittal BB, Haines GK, Pelzer HJ. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9 Head and Neck. 22: 328-335. PMID 10862014 DOI: 10.1002/1097-0347(200007)22:4<328::AID-HED3>3.0.CO;2-R  1
1999 Lingen MW. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents Critical Reviews in Oral Biology and Medicine. 10: 153-164. PMID 10759419  1
1999 Bentz BG, Pelzer HJ, Haines GK, Hanson DG, Lingen MW, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck Annals of Otology, Rhinology and Laryngology. 108: 781-787. PMID 10453787  1
1999 Dardick I, Birek C, Lingen MW, Rowe PE. Differentiation and the cytomorphology of salivary gland tumors with specific reference to oncocytic metaplasia Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 88: 691-701.  1
1998 Lingen MW, Polverini PJ, Bouck NP. Retinoic acid and interferon α act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma Cancer Research. 58: 5551-5558. PMID 9850093  1
1998 Lingen MW. Understanding the biology of oral cancer and chemoprevention Cds Review. 91: 24-28. PMID 9760890  1
1997 Lingen MW, DiPietro LA, Solt DB, Bouck NP, Polverini PJ. The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFbeta-1 and is unaffected by ras activation. Carcinogenesis. 18: 329-38. PMID 9054625 DOI: 10.1093/carcin/18.2.329  1
1996 Lingen MW, Polverini PJ, Bouck NP. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells Laboratory Investigation. 74: 476-483. PMID 8780165  1
1996 Janette A, Pecaro B, Lonergan M, Lingen MW. Solitary intraoral keratoacanthoma: Report of a case Journal of Oral and Maxillofacial Surgery. 54: 1026-1030. PMID 8765395 DOI: 10.1016/S0278-2391(96)90407-3  1
1996 Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ, Bouck NP. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats Journal of Clinical Investigation. 98: 671-679. PMID 8698858  1
1996 Lingen MW, Polverini PJ, Bouck NP. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic American Journal of Pathology. 149: 247-258. PMID 8686749  1
1996 Lingen MW, Polverini PJ, Bouck NP. Retinoic acid and interferon-alpha act synergistically to inhibit tumor angiogenesis Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 82: 212.  1
1995 Lingen MW, Rao SM, Hutten MC, Pelzer HJ. Primary ectopic meningioma of the maxillary sinus: case report and review of the literature. Head & Neck. 17: 258-62. PMID 7782212  1
1995 Lingen MW, Mostofi RS, Solt DB. Myofibromas of the oral cavity Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology And. 80: 297-302. PMID 7489273 DOI: 10.1016/S1079-2104(05)80387-7  1
1993 Lingen MW, Solt DB, Polverini PJ. Unusual presentation of a chondromyxoid fibroma of the mandible. Report of a case and review of the literature Oral Surgery, Oral Medicine, Oral Pathology. 75: 615-621. PMID 8304995 DOI: 10.1016/0030-4220(93)90236-W  1
Show low-probability matches.